SLRN
Price
$4.60
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
47 days until earnings call
THAR
Price
$2.94
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

SLRN vs THAR

Header iconSLRN vs THAR Comparison
Open Charts SLRN vs THARBanner chart's image
ACELYRIN
Price$4.60
Change-$0.00 (-0.00%)
Volume$1.25M
CapitalizationN/A
Tharimmune
Price$2.94
Change-$0.00 (-0.00%)
Volume$152.32K
CapitalizationN/A
View a ticker or compare two or three
SLRN vs THAR Comparison Chart
Loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
SLRN vs. THAR commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLRN is a StrongBuy and THAR is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (SLRN: $4.61 vs. THAR: $2.96)
Brand notoriety: SLRN and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLRN: 81% vs. THAR: 369%
Market capitalization -- SLRN: $460.12M vs. THAR: $3.43M
SLRN [@Biotechnology] is valued at $460.12M. THAR’s [@Biotechnology] market capitalization is $3.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLRN’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • SLRN’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, THAR is a better buy in the long-term than SLRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLRN’s TA Score shows that 5 TA indicator(s) are bullish while THAR’s TA Score has 3 bullish TA indicator(s).

  • SLRN’s TA Score: 5 bullish, 4 bearish.
  • THAR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SLRN is a better buy in the short-term than THAR.

Price Growth

SLRN (@Biotechnology) experienced а -8.17% price change this week, while THAR (@Biotechnology) price change was +0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.38%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1.46%.

Reported Earning Dates

SLRN is expected to report earnings on Nov 05, 2024.

THAR is expected to report earnings on Feb 28, 2024.

Industries' Descriptions

@Biotechnology (+7.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLRN($460M) has a higher market cap than THAR($3.44M). SLRN YTD gains are higher at: -38.204 vs. THAR (-61.231). THAR has higher annual earnings (EBITDA): -8.86M vs. SLRN (-375.08M). SLRN has more cash in the bank: 635M vs. THAR (7.9M). THAR has less debt than SLRN: THAR (560K) vs SLRN (1.07M). SLRN (0) and THAR (0) have equivalent revenues.
SLRNTHARSLRN / THAR
Capitalization460M3.44M13,392%
EBITDA-375.08M-8.86M4,233%
Gain YTD-38.204-61.23162%
P/E RatioN/A0.14-
Revenue00-
Total Cash635M7.9M8,042%
Total Debt1.07M560K191%
TECHNICAL ANALYSIS
Technical Analysis
SLRNTHAR
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
SLRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMSCX10.780.01
+0.09%
Praxis Small Cap Index A
IRSIX13.290.01
+0.08%
Voya Russell Small Cap Index Port A
NMVLX13.62N/A
N/A
Nuance Mid Cap Value Institutional
ISGLX15.47N/A
N/A
Columbia Integrated Small Cap Gr Adv
MITDX40.11-0.21
-0.52%
MFS Massachusetts Investors Tr R4

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with SEEL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then SEEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
+5.25%
SEEL - SLRN
41%
Loosely correlated
-11.56%
CMND - SLRN
40%
Loosely correlated
-1.49%
OABI - SLRN
38%
Loosely correlated
+0.66%
THAR - SLRN
36%
Loosely correlated
-1.00%
RCKT - SLRN
36%
Loosely correlated
-4.40%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with INSM. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
-1.00%
INSM - THAR
74%
Closely correlated
-0.52%
CALT - THAR
57%
Loosely correlated
+0.10%
SEEL - THAR
50%
Loosely correlated
-11.56%
CMND - THAR
47%
Loosely correlated
-1.49%
SNGX - THAR
46%
Loosely correlated
+10.77%
More